VRTX Bull Call Spread Strategy
VRTX (Vertex Pharmaceuticals Incorporated), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation. Its pipeline includes VX-864 for the treatment of AAT deficiency, which is in Phase 2 clinical trial; VX-147 for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases which is in Phase 2 clinical trial; VX- 880, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-548, a NaV1.8 inhibitor for treatments of acute, neuropathic, musculoskeletal pain which is in Phase 2 clinical trial; and CTX001 for the treatment severe SCD and TDT which is in Phase 3 clinical trial. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. It has collaborations with Affinia Therapeutics, Inc.; Arbor Biotechnologies, Inc.; CRISPR Therapeutics AG.; Kymera Therapeutics, Inc.; Mammoth Biosciences, Inc.; Moderna, Inc.; Obsidian Therapeutics, Inc.; and Skyhawk Therapeutics, Inc.; as well as Ribometrix, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany, and X-Chem, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.
VRTX (Vertex Pharmaceuticals Incorporated) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $114.99B, a trailing P/E of 26.54, a beta of 0.30 versus the broader market, a 52-week range of 362.5-507.92, average daily share volume of 1.3M, a public-listing history dating back to 1991, approximately 6K full-time employees. These structural characteristics shape how VRTX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.30 indicates VRTX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a bull call spread on VRTX?
A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width.
Current VRTX snapshot
As of May 15, 2026, spot at $436.98, ATM IV 27.56%, IV rank 26.31%, expected move 7.90%. The bull call spread on VRTX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this bull call spread structure on VRTX specifically: VRTX IV at 27.56% is on the cheap side of its 1-year range, which favors premium-buying structures like a VRTX bull call spread, with a market-implied 1-standard-deviation move of approximately 7.90% (roughly $34.53 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated VRTX expiries trade a higher absolute premium for lower per-day decay. Position sizing on VRTX should anchor to the underlying notional of $436.98 per share and to the trader's directional view on VRTX stock.
VRTX bull call spread setup
The VRTX bull call spread below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With VRTX near $436.98, the first option leg uses a $435.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed VRTX chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 VRTX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $435.00 | $15.30 |
| Sell 1 | Call | $460.00 | $5.40 |
VRTX bull call spread risk and reward
- Net Premium / Debit
- -$990.00
- Max Profit (per contract)
- $1,510.00
- Max Loss (per contract)
- -$990.00
- Breakeven(s)
- $444.90
- Risk / Reward Ratio
- 1.525
Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit.
VRTX bull call spread payoff curve
Modeled P&L at expiration across a range of underlying prices for the bull call spread on VRTX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$990.00 |
| $96.63 | -77.9% | -$990.00 |
| $193.25 | -55.8% | -$990.00 |
| $289.86 | -33.7% | -$990.00 |
| $386.48 | -11.6% | -$990.00 |
| $483.10 | +10.6% | +$1,510.00 |
| $579.72 | +32.7% | +$1,510.00 |
| $676.33 | +54.8% | +$1,510.00 |
| $772.95 | +76.9% | +$1,510.00 |
| $869.57 | +99.0% | +$1,510.00 |
When traders use bull call spread on VRTX
Bull call spreads on VRTX reduce the cost of a bullish VRTX stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
VRTX thesis for this bull call spread
The market-implied 1-standard-deviation range for VRTX extends from approximately $402.45 on the downside to $471.51 on the upside. A VRTX bull call spread caps both the risk and the reward of a bullish position; relative to an outright long call on VRTX, the spread reduces the cost basis but limits the maximum profit to the strike width minus net debit. Current VRTX IV rank near 26.31% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on VRTX at 27.56%. As a Healthcare name, VRTX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to VRTX-specific events.
VRTX bull call spread positions are structurally moderately bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. VRTX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move VRTX alongside the broader basket even when VRTX-specific fundamentals are unchanged. Long-premium structures like a bull call spread on VRTX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current VRTX chain quotes before placing a trade.
Frequently asked questions
- What is a bull call spread on VRTX?
- A bull call spread on VRTX is the bull call spread strategy applied to VRTX (stock). The strategy is structurally moderately bullish: A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width. With VRTX stock trading near $436.98, the strikes shown on this page are snapped to the nearest listed VRTX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are VRTX bull call spread max profit and max loss calculated?
- Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit. For the VRTX bull call spread priced from the end-of-day chain at a 30-day expiry (ATM IV 27.56%), the computed maximum profit is $1,510.00 per contract and the computed maximum loss is -$990.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a VRTX bull call spread?
- The breakeven for the VRTX bull call spread priced on this page is roughly $444.90 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current VRTX market-implied 1-standard-deviation expected move is approximately 7.90%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a bull call spread on VRTX?
- Bull call spreads on VRTX reduce the cost of a bullish VRTX stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
- How does current VRTX implied volatility affect this bull call spread?
- VRTX ATM IV is at 27.56% with IV rank near 26.31%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.